CARLSBAD, Calif., May 31, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the

The Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma (ONB).

A report published in the online journal Nature Biotechnology states that BGI has successfully completed the analysis and genome sequence of foxtail millet (Setaria italica).

Advanced high-speed gene-sequencing has been used in the clinical setting to find diagnoses for seven children out of a dozen who were experiencing developmental delays and congenital abnormalities for mysterious reasons.

Researchers at John Hopkins University found that whole genome sequencing may not help most people find out whether their at risk for common diseases or not.